Related Experiment Video

Updated: Jan 20, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Phase II Clinical Trial for Newly Diagnosed Children and Adolescents with Localized Lymphoblastic Lymphoma (Japanese

Masahiro Sekimizu1, Junichiro Fujimoto, Tetsuya Takimoto

  • 1Department of Pediatrics, Nagoya Medical Center, Nagoya 460-0001, Japan.masahiro.sekimizu@nnh.go.jp.

Acta Medica Okayama
|August 25, 2018
PubMed

Insights

The Berlin-Frankfurt-Munster (BFM) 90 protocol offers favorable outcomes for pediatric lymphoblastic lymphoma but causes late complications. This trial investigates a modified BFM regimen for safer, effective treatment in children.

Area of Science:

  • Pediatric Oncology
  • Hematologic Malignancies
  • Clinical Trial Design

Background:

  • The standard Berlin-Frankfurt-Munster (BFM) 90 protocol is used for pediatric lymphoblastic lymphoma.
  • This regimen, while effective, involves high doses of anthracycline and alkylating agents, leading to potential late complications.

Purpose of the Study:

  • To evaluate the efficacy and safety of a modified BFM regimen in pediatric patients with lymphoblastic lymphoma.
  • To establish a potentially safer and effective standard therapy for stage I/II lymphoblastic lymphoma.

Main Methods:

  • A phase II, nationwide multicenter clinical trial.
  • Involves a modified Berlin-Frankfurt-Munster (BFM) regimen.

Main Results:

  • Data on efficacy and safety of the modified regimen are currently being collected.
  • Expected to provide insights into the outcomes of the modified BFM protocol.

Conclusions:

  • The modified BFM regimen aims to reduce late complications associated with standard therapy.
  • This trial seeks to establish an improved treatment standard for pediatric lymphoblastic lymphoma.

Keywords:
efficacylimited stagelymphoblastic lymphomapediatricssafety

More Related Videos

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K
Clinical Trials01:16

Clinical Trials

10.2K

Related Concept Videos

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain03:26

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

The protocol outlines the surgical procedure for the treatment of postamputation pain using Targeted Muscle Reinnervation (TMR). TMR will be compared with two other surgical techniques, specifically Regenerative Peripheral Nerve Interface (RPNI) and neuroma excision, followed by immediate burying within muscle under the context of an international, randomized controlled...
3.5K
In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

This protocol demonstrates the workflow of the SILICOFCM platform for automatically generating a parametric model of the left ventricle from patient-specific ultrasound images by applying a multi-scale electromechanical model of the heart. This platform enables in silico clinical trials intended to reduce real clinical trials and maximize positive therapeutic...
2.2K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

In this report, we demonstrate the staining and analysis steps of a phenotyping assay performed on fresh whole blood to enumerate major innate and adaptive leukocyte populations. We emphasize considerations for performing these procedures in the context of a multicenter clinical...
15.5K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
398